Trademarkia Logo

Canada

C$
Accelera Pharma
FORMALIZED

on 2 Jan 2025

Last Applicant/ Owned by

Accelera Pharma Australia Pty Ltd

C/-o Beachhead Advantage,Level 16, 175 Pitt StreetSydney NSW 2000

AU

Serial Number

2372305 filed on 15th Oct 2024

Accelera Pharma

Trademark usage description

advertising services relating to pharmaceuticals; advertising services relating to pharmaceutical products; wholesale services for pharmaceutical, vet Read More

Classification Information


Class [035]
Advertising services relating to pharmaceuticals; advertising services relating to pharmaceutical products; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services in the field of pharmaceuticals; retail and wholesale services for diagnostic pharmaceutical products and diagnostic substances for medical use; retail and wholesale services for pharmaceuticals, medical and veterinary preparations; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations; retail and wholesale services in relation to pharmaceuticals; retail and wholesale services for pharmaceuticals.


Classification kind code

12

Class [044]
Provision of medical information in the field of pharmacological treatment; provision of information relating to drugs; drug information services; consultancy relating to pharmaceutical and medical products; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceutical products; consultancy and information services in the field of pharmaceutical.


Classification kind code

12

Mark Details


Serial Number

2372305

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 2th Jan 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Jan 2025
Created
Submitted for opposition 31
on 2th Jan 2025
Formalized
Submitted for opposition 228
on 15th Oct 2024
International Registration
Submitted for opposition 30
on 15th Oct 2024
Filed